Ceres Announces Fiscal First Quarter 2014 Financial Results

- Plantings for the 2013-2014 season successfully completed

- Company providing increased agronomy support to ethanol mills

- Expenditures in line with management's expectations

Jan 09, 2014, 16:05 ET from Ceres, Inc.

THOUSAND OAKS, Calif., Jan. 9, 2014 /PRNewswire/ -- Energy crop company Ceres, Inc. (Nasdaq: CERE) today announced financial results for the three months ended November 30, 2013 and provided an update on its business in Brazil.

The company reported that mill plantings for the 2013-2014 sorghum growing season in Brazil have been successfully completed on time and according to Ceres crop management protocols. Growing conditions have been generally favorable to date across most regions.

"The adjustments we have made to our go-to-market approach and product development processes have had a positive impact on the start of the season," said Richard Hamilton, President and Chief Executive Officer of Ceres. He noted that Ceres agronomists will continue to work closely with ethanol mills to help their agricultural teams gain confidence in producing the crop and adhering to the company's crop management protocols. "Our primary goal is to duplicate the individual successes we demonstrated last season across a broader range of customers and geographies," said Hamilton.

Chief Financial Officer Paul Kuc reported that expenses for the company's first fiscal quarter reflect operational changes and cost saving measures initiated during the quarter. "We expect expenditures to begin to decline in the near term as we prioritize our commercialization and product development activities in Brazil and remain vigilant over the use of our working capital," said Kuc.


  • Plantings of the company's sorghum hybrids for the 2013-2014 sorghum growing season in Brazil have been successfully completed with 49 customers, including mills and mill suppliers, across 55 different locations. As previously reported, these plantings consist primarily of smaller, multi-hybrid evaluations designed to determine yield potential and identify the best performing hybrids for specific regions.
  • As part of its product development process, Ceres has also established a number of breeding and product development field evaluations across various geographies. These trials consist of hundreds of hybrids, including a subset of hybrids in advanced evaluations in Brazil and other countries in South America that have demonstrated higher yields and other performance benefits over current products.
  • Total plantings of the company's commercial and pre-commercial sorghum hybrids cover approximately 1,000 hectares this season. Harvests are expected to commence in late February to early March and continue through May.
  • In December, the company successfully completed all elements of a multi-year project funded by a competitive grant from the U.S. Department of Energy's Advanced Research Project Agency for Energy (ARPA-E). The Ceres project consisted of multi-state field evaluations of the company's high yield, low input biotech traits in three energy crops. Based on the positive results of the project, Ceres has advanced a number of these traits in its product development pipeline.
  • During the quarter ended November 30, 2013, Ceres was awarded a U.S. patent related to a sorghum-derived gene promoter useful for regulating the expression of genes developed through biotechnology in various crops.


Total revenues for the quarter ended November 30, 2013 were $0.8 million compared to $2.0 million for the same period last year primarily due to lower collaborative research revenue and government grants. Product sales remained relatively unchanged compared to the first quarter of 2012.

Cost of product sales was $1.3 million for the quarter ended November 30, 2013 compared to $0.7 million for the same period last year. The increase was primarily due to costs related to the company's previously reported workforce reductions and expenses for obsolete seed inventory related to the company's sweet sorghum products.

Research and development expenses were $4.4 million for the three months ended November 30, 2013 compared to $4.3 million for the same period last year. In the U.S., research and development expenses decreased by $0.6 million primarily due to reduced external research and development expenses. In Brazil, research and development expenses increased by $0.7 million primarily as a result of increased personnel and related expenses.

Selling, general and administrative expenses decreased by $0.6 million to $3.3 million for the three months ended November 30, 2013 compared to the same period last year. In the U.S., expenses decreased by $0.7 million primarily due to reduced personnel and related expenses and lower professional fees. In Brazil, expenses increased by $0.1 million primarily as a result of increased personnel and related expenses.

For the quarter ended November 30, 2013, Ceres reported a net loss of $8.2 million, or $0.33 per share, compared to a net loss of $6.9 million, or $0.28 per share, for the quarter ended November 30, 2012.

At November 30, 2013, cash and cash equivalents and marketable securities totaled $24.4 million.

CONFERENCE CALL AND WEBCAST INFORMATION Ceres has scheduled a conference call for 4:30 p.m. EST (1:30 p.m. PST) today to discuss its fiscal first quarter results and to provide an update on its business. The webcast of the conference call may be accessed at investor.ceres.net. Audio of the teleconference is also available by dialing:

North America callers: (877) 838-4153

International callers: +1 (720) 545-0037

An audio replay of the call will be available two hours after the conclusion of the live call, and remain available on the Ceres website for 30 days.

2014 ANNUAL MEETING OF STOCKHOLDERS Ceres will hold its 2014 annual meeting of stockholders on March 7, 2014 at 11:00 a.m. PST at the W Hotel at 6250 Hollywood Blvd. in Los Angeles, California. Notice of the annual meeting, proxy materials and the company's annual report for the fiscal year ended August 31, 2013 will be mailed to stockholders of record as of January 21, 2014. Each attendee must be a Ceres stockholder as of the close of business on January 21, 2014 or hold a valid proxy for the annual meeting.

UPCOMING EVENTS Ceres is scheduled to present at World Bio Market 2014 on March 5, 2014 in The Netherlands.

ABOUT CERES Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand.

CERES FORWARD-LOOKING STATEMENTS This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products, anticipated yields and product performance, status of crop plantings, short-term and long-term business strategies, market and industry expectations, future operating metrics, and future results of operations and financial position, including anticipated cost savings from our plan to align expenditures, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.



Condensed Consolidated Statements of Operations 

(In thousands, except share and per share amounts)


 Three Months Ended November 30, 




 Product sales 

$              20

$              14

 Collaborative research and government grants 



     Total revenues 



Cost and operating expenses:

 Cost of product sales 



 Research and development 



 Selling, general and administrative 



     Total cost and operating expenses 



Loss from operations 



Interest expense 



Interest income 



Loss before income taxes 



Income tax expense



Net loss 

$       (8,205)

$       (6,894)

Basic and diluted net loss per share

$         (0.33)

$         (0.28)

Weighted average outstanding common shares used for net loss per share:

     Basic and diluted





Condensed Consolidated Balance Sheets 

(In thousands, except share amounts and par value)


November 30,

August 31,




Current assets:

 Cash and cash equivalents 

$               7,314

$         8,881

 Marketable securities



 Prepaid expenses 



 Accounts receivable






 Other current assets 



     Total current assets 



Property and equipment, net 



Other assets 



     Total long-term assets



     Total assets 

$             30,944

$       37,178

Liabilities and Stockholders' Equity

Current liabilities:

 Accounts payable and accrued expenses 

$               4,745

$         3,825

 Other current liabilities



 Current portion of long-term debt



     Total current liabilities 



Other non-current liabilites



Long-term debt, net of current portion 



     Total liabilities 



Commitments and contingencies

Stockholders' equity:

 Common stock and additional paid in capital, $0.01 par value; 490,000,000 shares authorized; 25,224,269 shares issued and outstanding at November 30, 2013; 24,897,199 shares issued and outstanding at August 31, 2013.



 Accumulated other comprehensive loss 



 Accumulated deficit 



     Total stockholders' equity 



Total liabilities and stockholders' equity 

$             30,944

$       37,178

SOURCE Ceres, Inc.